@FierceBiotech: Buoyed by 6-week hep C data, Achillion sets out to test even faster cure. Report | Follow @FierceBiotech
@JohnCFierce: $RGLS slides after hep C contender's results underwhelm investors. $RGLS down 17%; mixed data for hep C at this stage? More | Follow @JohnCFierce
@DamianFierce: Impressed Achillion has been so successful considering its name sounds like a 6-year-old trying to think of a really big number. | Follow @DamianFierce
> Melinta Therapeutics says it has lined up $30 million in debt financing. Release
> ALK and bioCSL today announced that they have entered into a long-term partnership covering three ALK products in Australia and New Zealand. Release
Medical Device News
@FierceMedDev: Medtronic settles with DOJ over false Medicare claims for neurostimulation devices. More | Follow @FierceMedDev
@VarunSaxena2: ICYMI: Study: Intuitive's da Vinci surgical robot enables more minimally invasive surgeries in kidney cancer patients. Story | Follow @VarunSaxena2
@EmilyWFierce: Quest and Myriad Genetics end BRCA patent battle. Release | Follow @EmilyWFierce
> U.S. DOJ probes Olympus over kickbacks, false marketing claims. More
> Swedish asthma diagnostic company Aerocrine raises $53M after recent FDA nod. News
Pharma News
@FiercePharma: Merck hands over #China joint venture to partner Simcere Pharma. News | Follow @FiercePharma
@CarlyHFierce: Daiichi's new clot-fighter Savaysa can't make up for $2.6B Benicar patent loss: analysts. More | Follow @CarlyHFierce
> FDA to pharma: Scrap that fine-print risk info in DTC ads. Story
> Drugmakers fall in line with Pakistani government's price-cutting plans. Article
> Roche boasts new Lucentis approval for retinal damage in diabetes. News
Biotech IT News
> FDA seeks budget boost for precision medicine IT infrastructure. More
> Apple edges ahead of Google in race to become a health data repository. Report
> Medidata posts 50% jump in partial SDV clients as risk-based monitoring takes off. Story
> TrialReach raises $13.5M for clinical trial-patient matching service. Item
> Merck joins Novartis, Pfizer on tech-enabled protein consortium with $6M buy in. Article
CRO News
> Quintiles' founder heads for the exit after 30-plus years as chairman. News
> BioClinica touts a big year for its eClinical biz. More
> TrialReach raises $13.5M to connect patients with studies. Story
> Icon buys a market-access firm for $120M. Article
> Covance ticks up revenue on the eve of a merger. Report
Animal Health News
> Ahead of AmerisourceBergen merger, MWI charts double-digit sales growth. Item
> New pet-care apps arm owners, veterinarians with mobile diagnostic tools. More
> Nexvet Biopharma sees sluggish market reception following IPO. Report
> Pet tear-stain removers still widely available despite FDA warnings. Story
> Pet owners jump on antivaccine bandwagon, ignoring veterinarians' advice. Article